Elafin (Trappin-2) ELISA Kit
Elafin, also known as skin-derived antileukoproteinase (SKALP), elastase-specific inhibitor (ESI), and Trappin-2, is an epithelial proteinase inhibitor belonging to the Trappin family. It plays an important role in regulating inflammation and protecting epithelial tissues from proteolytic damage. Elafin inhibits neutrophil-derived proteases, particularly neutrophil elastase and proteinase 3, and can be cross-linked to extracellular structures by transglutaminases. It is constitutively expressed in several epithelial tissues, including the hair follicles, esophagus, vagina, and oral cavity, and is strongly induced in skin during inflammatory processes such as psoriasis and wound healing. Elafin is initially synthesized as a 12.3 kDa precursor protein (pre-Elafin or Trappin-2), which is processed into a mature secreted form of approximately 9.9 kDa. A shorter 6 kDa form is also found in skin extracts, serum, and urine.
In research settings, Elafin is studied for its role in epithelial protection, protease regulation, and inflammatory responses. Its ability to inhibit neutrophil elastase and proteinase 3 makes it relevant to investigations of neutrophil-mediated tissue injury and inflammation. Researchers also examine Elafin expression in epithelial tissues and its involvement in wound healing, psoriasis, and other inflammatory conditions. Its different molecular forms and tissue distribution are important considerations when evaluating Elafin concentrations in biological samples.
In clinical research, Elafin has been investigated as a potential biomarker of inflammatory disease activity, particularly in psoriasis. Serum and plasma concentrations in healthy individuals are generally approximately 10–50 ng/mL and have been reported to increase up to tenfold in psoriasis. Changes in Elafin concentrations have also been used to monitor disease activity during cyclosporin treatment. Importantly, the ELISA is not suitable for measuring the shorter 6 kDa form of Elafin; however, the presence of this form does not interfere with the determination of the 9.9 kDa form. These characteristics should be considered when interpreting Elafin measurements in serum, plasma, and other biological samples.
This Elafin (Trappin-2) ELISA Kit is manufactured in Netherlands by Hycult Biotech.





